ATXN3 (Ataxin-3) — Gene Review Notes

UniProt: P54252 | HGNC: ATXN3 | Gene aliases: MJD, MJD1, SCA3, ATX3
Organism: Homo sapiens (NCBITaxon:9606)

Note on naming: the review was requested as "SCA3". SCA3 (spinocerebellar
ataxia type 3 / Machado-Joseph disease) is the disease; the HGNC gene
symbol is ATXN3. Per project convention (human = HGNC symbols) the
review is filed under ATXN3.

Provenance note: automated deep-research providers were unavailable in this
session (falcon returned HTTP 402 Payment Required; perplexity/asta/openscientist
not wired into the CLI provider enum). These notes are synthesized from the
cached UniProt record, the 18 cached publications, and Reactome. No
-deep-research-<provider>.md file was fabricated, per CLAUDE.md.

Summary

Ataxin-3 is a deubiquitinating enzyme (DUB) of the Josephin (Machado-Joseph
domain, MJD) cysteine-protease family. It is the protein whose gene, when its
CAG/polyglutamine tract expands beyond ~52 repeats, causes spinocerebellar
ataxia type 3 (SCA3) / Machado-Joseph disease
, the most common dominantly
inherited ataxia worldwide.

Domain architecture:
- Josephin domain (aa 1–180): catalytic papain-like cysteine-protease
DUB domain. Catalytic triad Cys14–His119–Asn134 (UniProt ACT_SITE 14,
119, 134; MUTAGENESIS of Cys-14 abolishes activity, PMID:23625928,
PMID:16118278, PMID:33157014).
- Ubiquitin-interacting motifs (UIMs): UIM1 (224–243), UIM2 (244–263),
and (isoform-dependent) UIM3 (331–349). UIMs bind ubiquitin and are
required to limit the length of ubiquitin chains.
- PolyQ tract (~aa 292 onward): normal 12–40 Gln; pathogenic when
expanded (~>52). The poly-Gln region also mediates interaction with BECN1.
- Multiple splice isoforms (P54252-1..-5); isoform composition affects the
C-terminal UIM3 and the tail (see PMID:30455355).

Molecular function — DUB activity and linkage specificity

Biological processes

  1. ERAD / retrotranslocation (endoplasmic-reticulum-associated degradation)
    Ataxin-3 is a p97/VCP-associated DUB that regulates retrotranslocation of
    ERAD substrates PMID:17000876. A later study shows it
    negatively regulates retro-translocation of nonubiquitinated substrates
    PMID:24068323. Supports GO:1904294 (positive regulation of ERAD pathway,
    IMP PMID:17000876) and ER-membrane colocalization (GO:0005789).

  2. Protein quality control / proteasomal degradation
    Interacts with STUB1/CHIP and the proteasome shuttle factors RAD23A/RAD23B
    (HHR23A/B) PMID:10915768. Restricts
    ubiquitin-chain length on CHIP substrates. Supports GO:0006515, GO:0043161.

  3. mTORC1 signaling (amino-acid starvation)
    Lysosome-localized ataxin-3 deubiquitinates RHEB; amino acids block this
    activity, so RHEB stays polyubiquitinated and mTORC1 is activated
    PMID:33157014.
    Supports GO:1904262 (negative regulation of TORC1 signaling),
    GO:0034198 (cellular response to amino acid starvation), and the
    lysosomal-membrane localization (GO:0005765).

  4. Autophagy
    Deubiquitinates BECN1 at Lys-402, stabilizing it and promoting
    starvation-induced autophagy; poly-Gln domain mediates the BECN1
    interaction (UniProt FUNCTION, PMID:28445460 — not in GOA set).

  5. Transcription regulation
    Histone-binding protein that represses transcription (UniProt FUNCTION,
    PMID:12297501). Acts with FOXO4 to regulate the SOD2 (MnSOD) promoter
    (Reactome R-HSA-9617832, R-HSA-9617927; Reactome pathway
    R-HSA-9615017 "FOXO-mediated transcription of oxidative stress ...").

  6. Cytoskeleton regulation
    Loss of ataxin-3 causes cytoskeletal disorganization and increased cell
    death PMID:20637808. Source for the four
    cytoskeleton acts_upstream_of_or_within IMP terms (GO:0000226,
    GO:0030036, GO:0045104, GO:0010810). These are downstream/pleiotropic
    phenotypes of a knockdown, best kept as non-core.

Localization

Predominantly cytoplasmic but shuttles to the nucleus and associates with the
nuclear matrix [PMID:9580663 "Ataxin-3 is transported into the nucleus and
associates with the nuclear matrix"; PMID:9124802 "Machado-Joseph disease gene
product is a cytoplasmic protein widely expressed in brain"]. Both cytosol
(GO:0005829) and nucleus/nucleoplasm (GO:0005634, GO:0005654) are supported.
Lysosomal membrane (GO:0005765) is supported in the mTORC1 context
(PMID:33157014). Nuclear inclusion bodies (GO:0042405) are the pathological
polyQ-aggregate hallmark.

Interactions of note (IPI protein-binding annotations)

Curation considerations for the annotation review

Update: Affinage deep-research integration (full-text verified)

Ran the endorsed Affinage integration (projects/AFFINAGE_EVALUATION/affinage_deep_research.py)
producing ATXN3-deep-research-affinage.md (gates passed; human; UniProt P54252
matches; self-eval pairwise=win; 24 citation-anchored findings). Fetched and
read the full text of the strongest normal-function findings and added two NEW
annotations. The DSB-repair role has since been promoted to a core
function (nuclear DUB activity on stalled RNAP II); the chromatin role is
kept non-core (catalytic-independent):

Other Affinage substrate-specific DUB findings (HDAC3/PMID:29802126, KLF4, YAP,
JunB/IRF1/STAT3/HIF-2α→PD-L1, EIF5A2; D2 retrotranslocation/PMID:24196352) are
instances of the already-annotated general deubiquitinase activity or are
cancer/disease-context roles; not added as separate process terms to avoid
substrate-level over-annotation. PMID:17764659 (Atxn3-KO mice accumulate
ubiquitinated proteins) corroborates the in-vivo DUB/PQC role. New full-text
references cached: PMID:32205441, PMID:30994454, PMID:36971114, PMID:24196352
(full text) and PMID:29802126, PMID:17764659 (abstract only).